TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-07
DOI
10.3389/fimmu.2022.832230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inference and analysis of cell-cell communication using CellChat
- (2021) Suoqin Jin et al. Nature Communications
- Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer
- (2021) Wenbin Zhou et al. Journal for ImmunoTherapy of Cancer
- Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
- (2021) Maosen Xu et al. CELL PROLIFERATION
- CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
- (2020) Nathan Karin Frontiers in Immunology
- Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
- (2020) Ester Lozano et al. CLINICAL CANCER RESEARCH
- Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
- (2020) David A. Palma et al. JOURNAL OF CLINICAL ONCOLOGY
- High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer
- (2020) Qinglin Fei et al. Cell Death & Disease
- TIGIT in cancer immunotherapy
- (2020) Joe-Marc Chauvin et al. Journal for ImmunoTherapy of Cancer
- Enhancing anti-tumour efficacy with immunotherapy combinations
- (2020) Funda Meric-Bernstam et al. LANCET
- Robotic versus Freehand Needle Positioning in CT-guided Ablation of Liver Tumors: A Randomized Controlled Trial
- (2019) Wouter J. Heerink et al. RADIOLOGY
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
- (2019) Melvyn T. Chow et al. IMMUNITY
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- CXCR3-CXCL9: It’s All in the Tumor
- (2019) Etienne Humblin et al. IMMUNITY
- Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
- (2019) Liangrong Shi et al. Nature Communications
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
- (2018) Nathan Karin et al. CYTOKINE
- CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression
- (2018) Palash Kumar Mandal et al. IMMUNOBIOLOGY
- A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung Tumors
- (2018) Kiri A. Sandler et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity
- (2018) Karen O. Dixon et al. JOURNAL OF IMMUNOLOGY
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Radiofrequency Ablation Followed by Surgical Excision versus Lumpectomy for Early Stage Breast Cancer: A Randomized Phase II Clinical Trial
- (2018) Amparo García-Tejedor et al. RADIOLOGY
- Targeting PVR (CD155) and its receptors in anti-tumor therapy
- (2018) Paola Kučan Brlić et al. Cellular & Molecular Immunology
- TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
- (2017) William C. Dougall et al. IMMUNOLOGICAL REVIEWS
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Targeting myeloid cells in the tumor sustaining microenvironment
- (2017) Jonathan Schupp et al. CELLULAR IMMUNOLOGY
- Reversing T-cell Dysfunction and Exhaustion in Cancer
- (2016) H. M. Zarour CLINICAL CANCER RESEARCH
- PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor
- (2016) L. Shi et al. CLINICAL CANCER RESEARCH
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
- (2016) Linnea Veinotte et al. OncoImmunology
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
- (2015) M. E. Mikucki et al. Nature Communications
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- The TIGIT/CD226 Axis Regulates Human T Cell Function
- (2012) E. Lozano et al. JOURNAL OF IMMUNOLOGY
- Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model
- (2012) JI-YE KEE et al. ONCOLOGY REPORTS
- CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway
- (2011) Chih-Hsin Tang et al. BIOCHEMICAL PHARMACOLOGY
- Vstm3 is a member of the CD28 family and an important modulator of T-cell function
- (2011) Steven D. Levin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Image-guided Thermal Ablation of Lung Malignancies
- (2011) Damian E. Dupuy RADIOLOGY
- CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer
- (2010) Ling Deng et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- CCL5 as an adjuvant for cancer immunotherapy
- (2010) Natalia Lapteva et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients
- (2008) Paul Gutwein et al. EUROPEAN JOURNAL OF CANCER
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started